Freeline Therapeutics Holdings PLC (FRLN)
FRLN has a market cap or net worth of $111.70 million. The enterprise value is -$52.98 million.
FRLN has 35.80 million shares outstanding.
|Shares Change (YoY)||n/a|
|Shares Change (QoQ)||+0.07%|
|Owned by Insiders (%)||8.24%|
|Owned by Institutions (%)||32.05%|
The stock's EV/EBITDA ratio is n/a, with a EV/FCF ratio of n/a.
|EV / Earnings||n/a|
|EV / Sales||n/a|
|EV / EBITDA||n/a|
|EV / EBIT||n/a|
|EV / FCF||n/a|
|Debt / Equity||n/a|
|Debt / EBITDA||n/a|
|Debt / FCF||n/a|
|Return on Equity (ROE)||-90.50%|
|Return on Assets (ROA)||-80.70%|
|Return on Capital (ROIC)||-827.80%|
|Revenue Per Employee||n/a|
|Profits Per Employee||-$584,208|
In the past 12 months, FRLN has paid $145,000 in taxes.
|Effective Tax Rate||-0.11%|
Stock Price Statistics
The stock price has decreased by -80.91% in the last 52 weeks.
|52-Week Price Change||-80.91%|
|50-Day Moving Average||3.56|
|200-Day Moving Average||6.82|
|Average Volume (30 Days)||103,049|
Short Selling Information
|Short % of Shares Out||0.21%|
|Short % of Float||0.61%|
|Short Ratio (days to cover)||0.38|
|Earnings Per Share (EPS)||-$5.06|
|Cash & Cash Equivalents||164.68M|
|Net Cash Per Share||$4.60|
|Book Value Per Share||5.18|
In the last 12 months, operating cash flow was -$131.80 million and capital expenditures -$4.50 million, giving a free cash flow of -$136.30 million.
|Operating Cash Flow||-131.80M|
|Free Cash Flow||-136.30M|
|FCF Per Share||-$3.81|
Dividends & Yields
FRLN does not appear to pay any dividends at this time.
|Dividend Per Share||n/a|
|Dividend Growth (YoY)||n/a|
This stock does not have any record of stock splits.
|Last Split Date||n/a|